RADIONETICS ONCOLOGY Trademark

Trademark Overview


On Thursday, October 21, 2021, a trademark application was filed for RADIONETICS ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the RADIONETICS ONCOLOGY trademark a serial number of 97085639. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, July 10, 2024. This trademark is owned by Radionetics Oncology, Inc.. The RADIONETICS ONCOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer

medical and pharmaceutical research services; pharmaceutical research and development; medical research for use in oncology; medical research services in the field of radiopharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others
radionetics oncology

General Information


Serial Number97085639
Word MarkRADIONETICS ONCOLOGY
Filing DateThursday, October 21, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, July 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements


Goods and Servicespharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related cancers; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; diagnostic radiopharmaceutical preparations; radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer
NOT AVAILABLE"ONCOLOGY"
Goods and Servicesmedical and pharmaceutical research services; pharmaceutical research and development; medical research for use in oncology; medical research services in the field of radiopharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRadionetics Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Party NameRadionetics Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Monday, October 25, 2021NEW APPLICATION ENTERED
Sunday, November 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 28, 2022ASSIGNED TO EXAMINER
Friday, July 29, 2022NON-FINAL ACTION E-MAILED
Friday, July 29, 2022NON-FINAL ACTION WRITTEN
Friday, July 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 29, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 2, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 7, 2023SOU EXTENSION 1 FILED
Wednesday, July 19, 2023ASSIGNED TO EXAMINER
Thursday, September 7, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 18, 2023SOU EXTENSION 1 GRANTED
Wednesday, July 10, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2024SOU EXTENSION 3 FILED
Wednesday, July 10, 2024SOU EXTENSION 3 GRANTED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 2 FILED
Tuesday, January 9, 2024SOU EXTENSION 2 GRANTED